Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.13 | 0.13 | 0.00 |
Stocks | 90.18 | 90.18 | 0.00 |
Convertible | 0.10 | 0.10 | 0.00 |
Preferred | 0.09 | 0.09 | 0.00 |
Other | 9.49 | 9.49 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.19 | 20.52 |
Price to Book | 5.25 | 4.45 |
Price to Sales | 2.03 | 2.44 |
Price to Cash Flow | 21.32 | 17.32 |
Dividend Yield | 0.73 | 1.11 |
5 Years Earnings Growth | 11.82 | 11.01 |
Number of long holdings: 141
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly and Co | - | 9.92 | - | - | |
Aggregate Miscellaneous Equity | - | 9.49 | - | - | |
UnitedHealth Group Inc | - | 6.07 | - | - | |
Intuitive Surgical Inc | - | 4.13 | - | - | |
Thermo Fisher Scientific Inc | - | 4.04 | - | - | |
Merck & Co Inc | - | 4.04 | - | - | |
Stryker Corp | - | 3.64 | - | - | |
Elevance Health Inc | - | 3.55 | - | - | |
Danaher Corp | - | 2.96 | - | - | |
Regeneron Pharmaceuticals Inc | - | 2.69 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 33.65B | 4.90 | 6.06 | 10.42 | ||
T. Rowe Price Blue Chip Growth | 32.31B | 17.02 | 5.95 | 14.08 | ||
T. Rowe Price Blue Chip Growth I | 29.12B | 17.08 | 6.09 | - | ||
T. Rowe Price Capital AppreciationI | 27.16B | 4.96 | 6.19 | - | ||
T. Rowe Price Instl Large Cap Growt | 22.15B | 14.17 | 6.81 | 15.36 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review